| # | Drug | Count |
|---|---|---|
| 0 | EZETIMIBE | 55 |
| 1 | ROSUVASTATIN | 53 |
| 2 | SIMVASTATIN | 47 |
| 3 | ATORVASTATIN CALCIUM | 40 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 40 |
| 5 | CIPROFLOXACIN | 35 |
| 6 | CIPROFLOXACIN TABLETS | 35 |
| 7 | CIPROFOLXACIN | 35 |
| 8 | DUPILUMAB | 35 |
| 9 | ACETAMINOPHEN | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECULIZUMAB-AEEB | 1 | 0.0909 |
| 1 | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0122 |
| 2 | BEMPEDOIC ACID | 14 | 0.0052 |
| 3 | FOSTEMSAVIR TROMETHAMINE | 1 | 0.0041 |
| 4 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 5 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 6 | BORON | 1 | 0.0033 |
| 7 | PAMABROM | 1 | 0.0027 |
| 8 | CALAMINE | 1 | 0.0023 |
| 9 | FERRIC OXIDE RED | 1 | 0.0022 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 15 | 0.0044 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 5 | 0.0011 |
| 3 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 7 | 0.0007 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 56 | 0.0006 |
| 6 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 7 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 8 | Quinolone Antimicrobial [EPC] | 5 | 0.0005 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |